Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 293
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05705700 | Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP) | ||
| NCT02989844 | Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCT | ||
| NCT03850691 | Radiation and Combination Immunotherapy for Melanoma | ||
| NCT00346125 | PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma | ||
| NCT04928950 | Charcoal in Lung Cancer Patients Undergoing TEMLA | ||
| NCT00625729 | Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia | ||
| NCT05447156 | QuitGuide for American Indians: Aims 2 & 3 | ||
| NCT01685411 | Busulfan and Cyclophosphamide Followed By ALLO BMT | ||
| NCT00287859 | Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer | ||
| NCT04466098 | Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19) | ||
| NCT00176878 | Stem Cell Transplant for Bone Marrow Failure Syndromes | ||
| NCT00725062 | Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant | ||
| NCT03728699 | Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy | ||
| NCT04629209 | A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma | ||
| NCT01526603 | High Dose Chemotherapy and Autologous Transplant for Neuroblastoma | ||
| NCT06322992 | App-Assisted Day Reconstruction to Reduce Treatment Burden and Logistic Toxicity in Cancer Patients - Aim 3 | ||
| NCT06213298 | Effect of Kava on Anxiety and Stress in Cancer Survivors | ||
| NCT00167206 | Stem Cell Transplantation for Fanconi Anemia | ||
| NCT00610740 | CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer | ||
| NCT00602693 | T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer | ||
| NCT00319748 | Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers | ||
| NCT02666105 | Exemestane in Post-Menopausal Women With NSCLC | ||
| NCT00392782 | Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease | ||
| NCT01312818 | Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) | ||
| NCT01181258 | Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies | ||
| NCT05708924 | MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer | ||
| NCT05123040 | Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids | ||
| NCT05700630 | Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia | ||
| NCT04714372 | FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia | ||
| NCT00428194 | Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer | ||
| NCT01451502 | Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units | ||
| NCT00176865 | Stem Cell Transplant for Immunologic or Histiocytic Disorders | ||
| NCT06772090 | Probiotic Supplementation During Cytotoxic Chemotherapy for Solid Tumor Malignancies | ||
| NCT00176891 | Stem Cell Transplant w/Laronidase for Hurler | ||
| NCT02722668 | UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep | ||
| NCT01581970 | Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer | ||
| NCT02074631 | Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation | ||
| NCT03642626 | MT2017-45: CAR-T Cell Therapy for Heme Malignancies | ||
| NCT06872333 | Allo HSCT for High Risk Hemoglobinopathies | ||
| NCT03557749 | Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies | ||
| NCT07153016 | LEgal Guidance and AdvocaCY for CAREgivers (LEGACY CARE): A Pilot Clinical Trial for Caregivers of Persons With Colorectal Cancer | ||
| NCT03050216 | QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML | ||
| NCT00400803 | Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer | ||
| NCT07008638 | Phase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagnosed TP53-mutated Acute Myeloid Leukemia (AML) | ||
| NCT00365287 | Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer | ||
| NCT04858594 | Study of Periodontitis and Blood Stream Infection in AML Patients Receiving Chemotherapy | ||
| NCT07541573 | GTB-5550 in Advanced Solid Tumors | ||
| NCT02046291 | Safety of Romiplostim (Nplate®) Following UCBT | ||
| NCT00622674 | Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors | ||
| NCT00352118 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer |
